Vigil Neuro
Meghan Pagliarini is currently the Office Manager at Vigil Neuro. Meghan has previous experience working as an Executive Assistant at Ipsen, MultiPlan, and Teva Pharmaceuticals. Prior to their work in the corporate world, Pagliarini was a substitute teacher for Burlington Public Schools and Lowell Public Schools. In 2016, they obtained their real estate license and began working as a Realtor for Keller Williams Realty in Reading, Massachusetts.
Meghan Pagliarini holds a Master of Education from Concordia University-Portland, where they majored in Curriculum & Instruction: Mathematics and graduated Summa Cum Laude with a 4.0 GPA. Meghan also holds a Bachelor's Degree in Leadership and Organizational Studies from Bay Path University. Her business education includes an Associates of Science Degree in Accounting from Bunker Hill CC and a Business Administration Accounting degree from Bunker Hill CC. Meghan is certified by the Massachusetts Department of Education in Middle School Mathematics, MTEL - Communication & Literacy (01), and Middle School Math 5-8.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.